UnitedHealth Group (NYSE:UNH) Trading Down 1.2% - Time to Sell?

UnitedHealth Group Stock Price Down 1.2% - Here's Why

Mar. 5, 2026 at 10:33pm

Got story updates? Submit your updates here. ›

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) was down 1.2% during trading on Thursday, with the company's stock price closing at $288.59. Approximately 5,353,235 shares changed hands, a decline of 47% from the average daily volume. Wall Street analysts have provided mixed forecasts for the company, with some reducing their target price while others maintaining a buy rating.

Why it matters

UnitedHealth Group is a major player in the healthcare industry, and its stock performance is closely watched by investors. The company's financial results and outlook can have a significant impact on the broader healthcare sector.

The details

The drop in UnitedHealth Group's stock price on Thursday was attributed to a decline in trading volume and mixed analyst forecasts. Some analysts have reduced their target price for the company, while others have maintained a buy rating. The company's stock has been trading in the range of $286.74 to $291.96 during the session.

  • UnitedHealth Group's stock price closed at $288.59 on Thursday, March 5, 2026.

The players

UnitedHealth Group Incorporated

A diversified healthcare company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum.

Morgan Stanley

A financial services firm that has reduced its target price for UnitedHealth Group.

Weiss Ratings

A ratings agency that has cut UnitedHealth Group's rating from a "hold (c-)" to a "sell (d+)".

Got photos? Submit your photos here. ›

What they’re saying

“UNH has been the topic of several recent research reports. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating on the stock in a report on Friday, January 23rd.”

— Morgan Stanley

“Weiss Ratings cut UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday.”

— Weiss Ratings

The takeaway

The mixed analyst forecasts and stock price decline for UnitedHealth Group highlight the volatility and uncertainty in the healthcare sector. Investors will be closely watching the company's future financial performance and strategic moves to gauge its long-term outlook.